genetic disease pipeline
Jan 24, 2019
BridgeBio bags $299M; Immunochina receives $20M; Attune raises; Wren receives $23M
BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic disease pipeline. This includes assets in preclinical and clinical development. Several therapeutic areas are being taken under the consideration of the pharma. Also, th...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
